GAO Says Multiple Year Funding Not Legal; Weicker Demands Assurance That Administration Will Comply
In Brief: Hayard Of Sloan-Kettering, Leder Of Harvard to Share 1985 Bristol-Myer Award Of $50,000
HHS Draft of Bill Reauthorizing NIH Specifically Kills Bypass Budget, Would End National Cancer Act of 1971
ACO Leaders Meet With Key White House, Hill Aides
ACCC Preliminary Report on DRGs Finds Case Mix Can Alter Profit/ Loss Pictures
Reagan Signs Skins Cancer Resolution
NCI advisory Group, Other Cancer Meetings
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - With five-year cancer survival at an all-time high, does this mean people are living longer?
- Blood Cancer United: A new name at the right moment
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.
- Premarin’s 84-year hold on the market ends as FDA approves a generic version
Trade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer
